Submission Details
| 510(k) Number | K130265 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2013 |
| Decision Date | June 23, 2014 |
| Days to Decision | 504 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K130265 is an FDA 510(k) clearance for the CONTOUR NEXT EZ BLOOD GLUCOSE METER, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by Bayer Healthcare, LLC (Mishawaka, US). The FDA issued a Cleared decision on June 23, 2014, 504 days after receiving the submission on February 4, 2013. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K130265 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 04, 2013 |
| Decision Date | June 23, 2014 |
| Days to Decision | 504 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |